Cervical intraepithelial neoplasia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Cervical intraepithelial neoplasia
File:VIAPosCIN1.gif Cervical intraepithelial neoplasia
Synonyms	Cervical dysplasia, CIN
Pronounce	N/A
Specialty	N/A
Symptoms	Often none; may include abnormal vaginal bleeding
Complications	Cervical cancer
Onset	Reproductive age
Duration	Variable
Types	N/A
Causes	Human papillomavirus (HPV) infection
Risks	Multiple sexual partners, early sexual activity, smoking, immunosuppression
Diagnosis	Pap smear, colposcopy, biopsy
Differential diagnosis	Cervicitis, vaginitis, endometrial hyperplasia
Prevention	HPV vaccination, safe sex practices
Treatment	Observation, cryotherapy, LEEP, cone biopsy
Medication	N/A
Prognosis	Good with treatment; risk of progression to cancer if untreated
Frequency	Common in women of reproductive age
Deaths	N/A

Cervical Intraepithelial Neoplasia (CIN)

Cervical Intraepithelial Neoplasia (CIN) is a precancerous condition in which abnormal cell growth occurs on the surface of the cervix. CIN is classified based on the extent of cell abnormality and is an important indicator for the risk of developing cervical cancer. It is categorized into low-grade and high-grade lesions, reflecting the severity of the cellular atypia and architectural changes without evidence of stromal invasion.

File:Cervical Intraepithelial Neoplasia HSIL 40X.jpg

A Pap smear micrograph showing changes associated with CIN.

Classification

CIN is classified into three grades, according to the degree of epithelial abnormality:

• CIN 1: Low-grade dysplasia, indicating mild abnormalities.
• CIN 2: Moderate dysplasia, considered high-grade but with lower risk than CIN 3.
• CIN 3: Severe dysplasia to carcinoma in situ, the highest precancerous stage.

Causes and Risk Factors

CIN is most commonly caused by persistent infection with high-risk types of Human Papillomavirus (HPV). Other risk factors include:

• Early sexual activity
• Multiple sexual partners
• Smoking
• Immunosuppression

Symptoms

CIN itself often presents no symptoms and is usually detected through routine cervical screening tests. If left untreated and progresses to cervical cancer, symptoms may include abnormal vaginal bleeding, pelvic pain, and pain during intercourse.

Diagnosis

Diagnosis of CIN involves:

• Pap smear tests: Screening for abnormal cells in the cervix.
• HPV testing: Identifying high-risk HPV strains.
• Colposcopy and biopsy: Further examination and tissue sampling if abnormal cells are found.

Treatment

Treatment depends on the grade of CIN:

• CIN 1: Often resolves spontaneously; regular monitoring is recommended.
• CIN 2 and CIN 3: May require more active treatment, such as cryotherapy, laser therapy, or surgical removal of the affected tissue.

Prevention and Screening

Preventive measures include HPV vaccination and regular cervical screening (Pap tests and HPV testing) to detect changes early. These strategies significantly reduce the incidence of cervical cancer.

See Also

• Human Papillomavirus (HPV)
• Cervical cancer
• Pap smear
• Colposcopy

References

• American Cancer Society. (2021). Cervical Cancer, HPV, and Cervical Dysplasia.
• World Health Organization. (2020). Human papillomavirus (HPV) and cervical cancer.

External Links

• American Cancer Society: Cervical Cancer
• World Health Organization: HPV and Cervical Cancer